Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Unusually-High Trading Volume - Time to Buy?

Key Points

• Bayer Aktiengesellschaft saw a significant **233% increase** in trading volume, with 2,746,917 shares exchanged on Wednesday, pushing the stock price up to **$7.79**.
• Multiple brokerages have upgraded their ratings for Bayer, with HSBC Global Res and Goldman Sachs both moving their ratings to **"strong-buy"**, indicating growing confidence in the stock.
• The company reported **$0.35 EPS**, exceeding analysts' expectations of $0.25, alongside a revenue of **$12.42 billion**, which was also above forecasts.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) saw an uptick in trading volume on Wednesday . 2,746,917 shares changed hands during trading, an increase of 233% from the previous session's volume of 825,115 shares.The stock last traded at $7.79 and had previously closed at $7.60.

Analyst Ratings Changes

Several brokerages have issued reports on BAYRY. Hsbc Global Res upgraded Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, June 11th. Kepler Capital Markets upgraded Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a report on Wednesday, June 11th. The Goldman Sachs Group upgraded Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a report on Thursday, June 5th. Finally, Wall Street Zen upgraded Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a report on Sunday. One investment analyst has rated the stock with a hold rating, two have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, Bayer Aktiengesellschaft presently has an average rating of "Buy".

Bayer Aktiengesellschaft Price Performance

The company has a current ratio of 1.25, a quick ratio of 0.79 and a debt-to-equity ratio of 1.07. The firm has a market cap of $30.73 billion, a P/E ratio of -8.06 and a beta of 0.91. The firm has a 50-day simple moving average of $7.84 and a 200-day simple moving average of $6.77.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $0.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.10. The business had revenue of $12.42 billion for the quarter, compared to analysts' expectations of $10.79 billion. Bayer Aktiengesellschaft had a positive return on equity of 15.48% and a negative net margin of 7.61%. As a group, analysts forecast that Bayer Aktiengesellschaft will post 1.31 EPS for the current year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.